A PRIM approach to predictive-signature development for patient stratification. Academic Article uri icon

Overview

abstract

  • Patients often respond differently to a treatment because of individual heterogeneity. Failures of clinical trials can be substantially reduced if, prior to an investigational treatment, patients are stratified into responders and nonresponders based on biological or demographic characteristics. These characteristics are captured by a predictive signature. In this paper, we propose a procedure to search for predictive signatures based on the approach of patient rule induction method. Specifically, we discuss selection of a proper objective function for the search, present its algorithm, and describe a resampling scheme that can enhance search performance. Through simulations, we characterize conditions under which the procedure works well. To demonstrate practical uses of the procedure, we apply it to two real-world data sets. We also compare the results with those obtained from a recent regression-based approach, Adaptive Index Models, and discuss their respective advantages. In this study, we focus on oncology applications with survival responses.

publication date

  • October 27, 2014

Research

keywords

  • Breast Neoplasms
  • Clinical Trials as Topic
  • Lymphoma, Large B-Cell, Diffuse
  • Neoplasms
  • Patient Selection
  • Pharmacogenetics
  • Predictive Value of Tests

Identity

PubMed Central ID

  • PMC4285951

Scopus Document Identifier

  • 84916228481

Digital Object Identifier (DOI)

  • 10.1002/sim.6343

PubMed ID

  • 25345685

Additional Document Info

volume

  • 34

issue

  • 2